Division of Cardiology, University of Colorado School of Medicine, 1700 N. Wheeling Street, Aurora, CO, 80045, USA.
Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, USA.
Curr Cardiol Rep. 2022 Jul;24(7):807-815. doi: 10.1007/s11886-022-01702-8. Epub 2022 Apr 30.
The past decade has brought increased efforts to better understand causes for ACS readmissions and strategies to minimize them. This review seeks to provide a critical appraisal of this rapidly growing body of literature.
Prior to 2010, readmission rates for patients suffering from ACS remained relatively constant. More recently, several strategies have been implemented to mitigate this including improved risk assessment models, transition care bundles, and development of targeted programs by federal organizations and professional societies. These strategies have been associated with a significant reduction in ACS readmission rates in more recent years. With this, improvements in 30-day post-discharge mortality rates are also being appreciated. As we continue to expand our knowledge on independent risk factors for ACS readmissions, further strategies targeting at-risk populations may further decrease the rate of readmissions. Efforts to understand and reduce 30-day ACS readmission rates have resulted in overall improved quality of care for patients.
过去十年，人们越来越努力地了解 ACS 再入院的原因，并寻找策略将其最小化。本综述旨在对这一日益增长的文献进行批判性评估。
2010 年之前，ACS 患者的再入院率相对稳定。最近，已经实施了几种策略来减轻这种情况，包括改进风险评估模型、过渡护理包，以及联邦组织和专业协会制定的针对性计划。这些策略与近年来 ACS 再入院率的显著降低有关。因此，出院后 30 天死亡率的改善也得到了认可。随着我们对 ACS 再入院的独立风险因素的了解不断加深，针对高危人群的进一步策略可能会进一步降低再入院率。为了解决和降低 30 天 ACS 再入院率，我们已经为患者提供了整体上更好的护理质量。
